Roles of conserved ectodomain cysteines of the rat P2X4 purinoreceptor in agonist binding and channel gating

Physiological Research

Volumn 59, Issue 6, 2010, Pages 927-935

  Rokic, M B ^a   Tvrdonova V ^a   Vavra V ^a   Jindrichova M ^a   Obsil T ^b   Stojilkovic, S S ^c   Zemkova H ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

ATP gated receptor channels; Deactivation; Disulfide bonds; Ivermectin; Purinergic signaling

Indexed keywords

CYSTEINE; PURINERGIC P2X4 RECEPTOR;

ANIMAL; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CHANNEL GATING; CHEMISTRY; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RAT;

ANIMALS; BINDING SITES; CONSERVED SEQUENCE; CYSTEINE; HEK293 CELLS; HUMANS; ION CHANNEL GATING; RATS; RECEPTORS, PURINERGIC P2X4;

EID: 78651418254     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Clyne JD, Wang LF, Hume RI. Mutational analysis of the conserved cysteines of the rat P2X2 purinoceptor. J Neurosci 22: 3873-3880, 2002.
2. Coddou C, Acuna-Castillo C, Bull P, Huidobro-Toro JP. Dissecting the facilitator and inhibitor allosteric metal sites of the P2X4 receptor channel: critical roles of CYS132 for zinc potentiation and ASP138 for copper inhibition. J Biol Chem 282: 36879-36886, 2007.
3. Ennion S, Hagan S, Evans RJ. The role of positively charged amino acids in ATP recognition by human P2X1 receptors. J Biol Chem 275: 29361-29367, 2000.
4. Ennion SJ, Evans RJ. Conserved cysteine residues in the extracellular loop of the human P2X1 receptor form disulfide bonds and are involved in receptor trafficking to the cell surface. Mol Pharmacol 61: 303-311, 2002.
5. 2+ sensing modulatory sites. J Biol Chem 279: 53109-53115, 2004.
6. Friday SC, Hume RI. Contribution of extracellular negatively charged residues to ATP action and zinc modulation of rat P2X2 receptors. J Neurochem 105: 1264-1275, 2008.
7. Jarvis MF, Khakh BS. ATP-gated P2X cation-channels. Neuropharmacology 56: 208-215, 2009.
8. Jelínková I, Yan Z, Liang Z, Moonat S, Teisinger J, Stojilkovic SS, Zemková H. Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem Biophys Res Commun 349: 619-625, 2006.
9. Jiang LZH, Rassendren F, Surprenant A, North RA. Identification of amino acid residues contributing to the ATP-binding site of a purinergic P2X receptor. J Biol Chem 275: 34190-34196, 2000.
10. Kawate T, Michel JC, Birdsong WT, Gouaux E. Crystal structure of the ATP-gated P2X4 ion channel in the closed state. Nature 460: 592-598, 2009.
11. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature 442: 527-532, 2006.
12. Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, Lester HA. Allosteric control of gating and kinetics at P2X4 receptor channels. J Neurosci 19: 7289-7299, 1999.
13. Nicke A, Baumert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E, Schmalzing G. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 17: 3016-3028, 1998.
14. North RA. Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067, 2002.
15. Priel A, Silberberg SD. Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol 123: 281-293, 2004.
16. Rassendren F, Buell G, Newbolt A, North RA, Surprenant A. Identification of amino acid residues contributing to the pore of a P2X receptor. Embo J 16: 3446-3454, 1997.
17. Roberts JA, Evans RJ. ATP binding at human P2X1 receptors. Contribution of aromatic and basic amino acids revealed using mutagenesis and partial agonists. J Biol Chem 279: 9043-9055, 2004.
18. Roberts JA, Evans RJ. Contribution of conserved polar glutamine, asparagine and threonine residues and glycosylation to agonist action at human P2X1 receptors for ATP. J Neurochem 96: 843-852, 2006.
19. Silberberg SD, Li M, Swartz KJ. Ivermectin interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron 54: 263-274, 2007.
20. Surprenant A, North RA. Signaling at purinergic P2X receptors. Annu Rev Physiol 71: 333-359, 2009.
21. Toulme E, Soto F, Garret M, Boue-Grabot E. Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Mol Pharmacol 69: 576-587, 2006.
22. Yan Z, Liang Z, Obšil T, Stojilkovic SS. Participation of the Lys313-Ile333 sequence of the purinergic P2X4 receptor in agonist binding and transduction of signals to the channel gate. J Biol Chem 281: 32649-32659, 2006.
23. Yan Z, Liang Z, Tomic M, Obšil T, Stojilkovic SS. Molecular determinants of the agonist binding domain of a P2X receptor channel. Mol Pharmacol 67: 1078-1088, 2005.
24. Yi CL, Liu YW, Xiong KM, Stewart RR, Peoples RW, Tian X, Zhou L, Ai YX, Li ZW, Wang QW, Li CY. Conserved extracellular cysteines differentially regulate the inhibitory effect of ethanol in rat P2X4 receptors. Biochem Biophys Res Commun 381: 102-106, 2009.
25. Zemková H, Yan Z, Liang Z, Jelínková I, Tomic M, Stojilkovic SS. Role of aromatic and charged ectodomain residues in the P2X4 receptor functions. J Neurochem 102: 1139-1150, 2007.